Parenteral nutrition (PN) is a lifesaving means of nutritional support for thousands of hospitalized infants who cannot tolerate normal oral feeding due to the immaturity or surgical removal of the intestine due to congenital or disease-related causes. PN is a method of delivering nutrients directly into the bloodstream via an intravenous catheter, bypassing the digestive system entirely.

A serious complication of PN is the risk for a metabolic condition called parenteral nutrition-associated liver disease (PNALD), which can lead to liver failure if not managed. PNALD can affect up to 50% of premature infants given total PN for prolonged periods. This study investigated a way to protect the liver from long-term injury that occurs when bile flow from the liver is obstructed.

Researchers from King’s College London have found that molecules in stool samples can accurately reflect what people eat and how their gut microbiome responds, offering a potential new tool to study nutrition and its impact on health.

Within a year of initiation, a multidisciplinary project to improve screening and treatment for iron deficiency in pregnancy resulted in a sixfold rise in screening rates for iron deficiency in pregnant patients, a 20-fold rise in the number of intravenous (IV) iron infusions, and a significant improvement in median hemoglobin levels.

Simplifying nutrition information can empower consumers to make healthier, more informed dietary choices and reduce their risk of cardiovascular disease (CVD), according to guidance issued by the American College of Cardiology and published in JACC, its flagship journal. The new guidance supports a standardized front-of-packaging food labeling system that highlights key nutrients to limit or encourage.